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Innate ImmunIty and nK cells
The immune system is classically divided 
into innate and adaptive. Adaptive immu-
nity can be defined by the presence of cells 
(i.e., T and B lymphocytes in higher ver-
tebrates) that clonally express a colossal 
repertoire of receptors (i.e., the T cell and 
the B cell antigen receptors), the diversity of 
which results from somatic DNA rearrange-
ments. Besides T and B cells, natural killer 
(NK) cells have been originally defined as 
cytolytic lymphocytes that selectively elimi-
nate tumor cells without antigen-specific 
receptors (Oldham and Herberman, 1973; 
Herberman et al., 1975; Kiessling et al., 
1975). NK cells are lymphocytes of the 
innate immune system that can kill an 
array of target cells and secrete cytokines 
that participate to the shaping of the adap-
tive immune response (Vivier et al., 2008, 
2011). A feature of NK cells resides in their 
capacity to distinguish stressed cells (such 
as tumor cells, microbe-infected cells, cells 
which have undergone physical or chemical 
injuries) from normal cells via an array of 
germline-encoded recognition receptors.
The acquisition of cell cytotoxicity dur-
ing evolution has been associated with the 
development of highly sophisticated and 
robust mechanisms that control the ini-
tiation of the cytolytic processes and avoid 
tissue damage. Along this line, much pro-
gress has been made over the last 15 years 
in the dissection of the mechanisms that 
allow NK cells to discriminate target cells 
from other healthy “self” cells. These data 
have been instrumental in defining several 
immune recognition strategies and in the 
emergence of the “dynamic equilibrium 
concept.” The NK cell detection system 
includes a variety of cell surface activating 
and inhibitory receptors, the engagement 
of which regulates NK cell activities. Thus, 
the integration of antagonistic pathways 
upon interaction with neighboring cells 
governs the dynamic equilibrium regulating 
NK cell activation and dictates whether or 
not NK cells are activated to kill target cells 
(Moretta and Moretta, 2004; Vivier et al., 
2004; Lanier, 2005).
mIssIng-self and nK cell 
educatIon
Natural killer cells use inhibitory recep-
tors to gauge the absence of constitutively 
expressed self-molecules on susceptible 
target cells. In particular, NK cells express 
MHC class I-specific receptors and “lose” 
inhibitory signals when encountering 
MHC class I-deficient hematopoietic cells 
in several in vitro and in vivo models. As a 
consequence, NK cells can recognize “miss-
ing self” on hematopoietic cells (Kärre 
et al., 1986; Bix et al., 1991). The MHC 
class I-specific inhibitory receptors include 
the killer cell immunoglobulin-like recep-
tors (KIRs) in humans, the lectin-like Ly49 
dimers in the mouse and the lectin-like 
CD94-NKG2A heterodimers in both species 
(Yokoyama and Plougastel, 2003; Parham, 
2005). A conserved feature of these inhibi-
tory receptors resides in the presence of one 
or two intracytoplasmic inhibitory signaling 
domains called immunoreceptor tyrosine-
based inhibition motifs (ITIMs; Burshtyn 
et al., 1996; Olcese et al., 1996). By interact-
ing with MHC class I molecules that are con-
stitutively expressed by most healthy cells in 
steady-state conditions but that may be lost 
upon stress, inhibitory MHC class I recep-
tors provide a way for NK cells to ensure tol-
erance to self while allowing toxicity toward 
stressed cells. MHC class I is not the only 
constitutive self-signal detected by NK cells, 
as other inhibitory receptors (for example, 
mouse NKR-P1B, human NKR-P1A, and 
mouse 2B4) that recognize non-MHC self-
molecules (for example, Clr-b, LLT-1, and 
CD48, respectively) also regulate NK cell 
activation (Kumar and McNerney, 2005).
MHC class I-specific inhibitory receptors 
and their ligands (H-2 in mice and HLA in 
humans) are highly polymorphic molecules 
encoded by multigenic,  multiallelic families 
of genes that are inherited independently 
(Yokoyama and Plougastel, 2003; Parham, 
2005). NK cells have thus to discriminate 
self in a context where self-molecules dif-
fer from individuals to individuals. Like T 
lymphocytes, NK cells are educated to self 
versus altered-self discrimination. This 
education, also termed “tuning, licens-
ing, or arming” leads to the maturation 
of a NK cell functional repertoire (i.e., the 
ensemble of stimulations toward which NK 
cells are reactive), which is adapted to self-
MHC class I environment (Fernandez et al., 
2005; Kim et al., 2005; Anfossi et al., 2006; 
Raulet and Vance, 2006; Yokoyama and Kim, 
2006). Consequently, NK cells in MHC 
class I-deficient hosts are hyporesponsive 
to stimulatory receptor stimulation and 
thereby tolerant to self. Other studies have 
reported that the hyporesponsiveness of NK 
cells grown in a MHC class I-deficient envi-
ronment can be overcome by inflammatory 
conditions in NK cell environment (Tay 
et al., 1995; Orr et al., 2010). It remains that 
two types of self-tolerant NK cells coexist 
in vivo at steady-state: functionally compe-
tent NK cells, whose effector responses are 
inhibited by the recognition of self-MHC 
class I molecules, and hyporesponsive NK 
cells that cannot detect self-MHC class I. NK 
cell education does not result in an on/off 
switch, but rather in a quantitative tuning of 
NK cell responsiveness: the more inhibitory 
receptors recognizing self-MHC class I are 
expressed, the more NK cells are respon-
sive to cells lacking self-MHC class I (Brodin 
et al., 2009; Joncker et al., 2009; Hoglund 
and Brodin, 2010). The molecular mecha-
nisms underlying the MHC-dependent NK 
cell education have been shown in mice to 
require a functional ITIM in the intracy-
toplasmic tail of Ly49 inhibitory receptors 
(Kim et al., 2005). Recently using spot vari-
able fluorescence correlation spectroscopy 
to monitor the movement of receptors, we 
have shown that in NK cells genetically 
engineered to not be properly educated, 
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can therefore give rise to a population of 
long-lived cells with an intrinsic ability to 
exhibit enhanced effector functions when 
restimulated. Supporting these observations, 
NK cells activated in vitro by cytokines (IL-
12/IL-18) and adoptively transferred in vivo 
also display some “ memory-like” properties 
(Cooper et al., 2009). In this model, after 
an episode of “activation-driven” prolifera-
tion, a population of apparently resting cells 
with an enhanced ability to secrete IFN-γ ex 
vivo is maintained during at least 3 weeks. 
Notably, this increased ability to secrete 
IFN-γ was observed regardless of the cell 
generation. Thus, NK cells can retain in vivo 
an intrinsic memory of a prior in vitro 
activation, which is maintained across cell 
divisions. Altogether, these results prompt 
to research into the mechanisms that allow 
the boosted effector function of NK cells to 
be maintained across cell divisions, in par-
ticular the epigenetic marks associated with 
various stages of these cells’ activation.
Besides, the “memory-like” features 
of NK cells also prompt to investigate 
how they participate in immunological 
memory. The ultimate goal of a vaccine 
is to develop long-lived immunological 
protection, whereby the first encounter 
with a pathogen is remembered and leads 
to an enhanced immune response. Novel 
insights into the cellular and molecular 
mechanisms controlling the develop-
ment and function of the immunological 
memory are therefore critical for vaccine 
development and improvement. There 
are several reports showing that NK cells 
interfere with the shaping of the adaptive 
immune response (Raulet, 2004), but very 
few address specifically the role of NK cells 
in immunological memory (Raulet, 2004; 
Soderquest et al., 2011). Concerning pri-
mary responses, NK cells can meet den-
dritic cells (DC) in peripheral tissues, as 
well as in secondary lymphoid organs, 
and can act on them in two distinct ways 
(Moretta, 2002; Degli-Esposti and Smyth, 
2005; Walzer et al., 2005). Upon interac-
tion, NK cells can kill immature DC in 
humans and mice, thereby influencing DC 
homeostasis, but also potentially limiting 
DC-based vaccination efficacy. Conversely, 
the killing of target cells by NK cells can 
lead to the cross-presentation of antigens 
from apoptotic NK cell targets by subsets 
of DCs. This NK cell-mediated cytotoxicity 
other NKG2D
+ lymphocytes) to attack the 
diseased cells (Gasser et al., 2005; Gasser and 
Raulet, 2006).
Besides NKG2D, NK cell express an 
array of cell surface molecules, such as 
the natural cytotoxicity receptors (NCR), 
which have been shown since more than 
a decade to be involved in the activation 
of NK cells by tumor cells (Moretta et al., 
2001). The NCR family includes NKp46 
(NCR1, CD335), NKp44 (NCR2, CD336), 
and NKp30 (NCR3, CD337; Bottino et al., 
2006). However, the NCR ligands that 
are expressed on tumor cells and activate 
NK cells are still unknown at the notice-
able exception of B7-H6 that we recently 
identified as a ligand for NKp30 (Brandt 
et al., 2009). One important aspect of future 
research in NK cells, will be to character-
ize the nature and the regulation of NCR 
ligands.
nK cells and ImmunologIcal 
memory
The immune system, like the nervous sys-
tem, has this ability to learn from previous 
experience, such as a single encounter with 
the many pathogens that exist. The result is 
immunological memory that confers long-
lasting protection. Until now, immunologi-
cal memory was thought to be a feature of 
the adaptive immune system. Unexpectedly, 
recent studies revealed that NK cells could 
be players in the persistence of immunity, 
although they have traditionally been con-
sidered to be part of the innate immune 
system. First, a seminal study showed that 
in mice lacking T and B cells, a subset of 
liver NK cells are able to mediate the pro-
totypical “adaptive” immune reaction of 
hapten-specific contact hypersensitivity 
(O’Leary et al., 2006; Paust et al., 2010). 
More recently, in a model of murine cyto-
megalovirus (MCMV), mouse NK cells 
expressing the receptor Ly49H, which rec-
ognizes the MCMV m157 protein, was 
shown to clonally expand and subsequently 
contract while leaving a few long-lived cells 
able to mount a “secondary” response (Sun 
et al., 2009; Ugolini and Vivier, 2009). These 
“virus-experienced” cells are still detectable 
up to 3 months after infection and display 
enhanced IFN-γ secretion and degranulation 
compared to naïve cells when restimulated 
ex vivo. Finally, when transferred to naïve 
immunocompromised mice, these cells are 
more protective against a lethal virus chal-
inhibitory and activating receptors were 
confined together in domains where they 
were associated with an actin network at the 
plasma membrane (Guia et al., 2011). When 
these cells were educated by MHC class I 
recognition, inhibitory receptors remained 
associated with an actin meshwork at the 
membrane, while activating receptors were 
present in nanodomains characteristic of 
active receptor signaling (Guia et al., 2011). 
This mechanism, as compared to transcrip-
tional reprogramming, may allow the NK 
cells greater flexibility to switch between an 
unresponsive state and a state in which they 
are competent to respond to stimuli, con-
sistent with recent NK cell adoptive trans-
fer experiments (Elliott et al., 2010; Joncker 
et al., 2010).
stress-Induced self recognItIon
Besides the detection of self via inhibitory 
receptors, NK cells are also equipped with 
cell surface activating receptors. In addition 
to the recognition of microbial molecules 
by a variety of innate immune receptors, 
the so-called “infectious non-self recogni-
tion,” it has been shown that some receptors 
of innate immune cells can detect internal 
changes, leading to the concept of “stress-
induced self recognition” (Bauer et al., 1999; 
Gasser et al., 2005; Guerra et al., 2008; Raulet 
and Guerra, 2009). This mode of detection 
is based on the recognition of molecules 
whose expression is barely detectable in 
steady-state conditions, but induced upon 
various forms of stress. A prototypical exam-
ple of this mode of detection is illustrated by 
the activation of NK cells via engagement of 
the NKG2D receptor, which interacts with 
self-molecules selectively up-regulated on 
stressed cells, such as tumor cells. In vivo, 
NKG2D is critical for immunosurveillance 
of epithelial and lymphoid malignancies in 
transgenic models of de novo tumorigen-
esis (Guerra et al., 2008). In the transgenic 
Eμ-Myc mouse model of spontaneous B 
cell lymphoma, the tumor expression of 
NKG2D ligands was shown to represent an 
early step of tumorigenesis associated with 
still unknown genetic lesions of cancer cells 
(Unni et al., 2008). A linkage between tumo-
rigenesis, DNA damage response (DDR) and 
the immune response has been proposed: 
DNA-damaging agents or DNA lesions 
associated with   tumorigenesis   activate 
the DDR, which results in   up-  regulation 
of NKG2D ligands leading NK cells (and 
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and mode of action remain to be unveiled. 
Frontiers in NK cell biology provides a plat-
form to highlight new knowledge on key 
aspects of NK cell biology from the nano-
scopic to the organismal scales. In addition, 
Frontiers in NK cell biology has the ambi-
tion to also apply to human immunology by 
bridging basic and translational research to 
open novel therapeutic perspectives.
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conclusIons
Studies on NK cells, which integrate their 
function as a result of their education 
and their mode of recognition of target 
cells, have already provided a novel con-
ceptual framework for the study of innate 
immunity that can serve as an inspira-
tion for the study of other hematopoietic 
cells. The experimental evidence of the 
role of NK cells as innate components 
of the host defense against some viruses 
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biology, their standard monitoring (e.g., 
in vitro lysis of K562 leukemia cells) should 
be revisited, implemented, and interna-
tionally standardized. Furthermore, the 
detection of NK cell ligands of tumor 
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Thus, almost 40 years after their discov-
ery and despite the growing interest in both 
basic and clinical aspects of NK cell  biology, 
of target cells induces robust antigen-spe-
cific adaptive immune responses involving 
CD8
+ T cells, CD4+ T cells and antibodies 
(Krebs et al., 2009). Recognition and kill-
ing of target cells by NK cells might thus 
provide a new and powerful strategy for 
vaccine development. NK cells can also 
influence adaptive immune responses 
by directly acting on T and B cells. In 
the inflamed lymph node, NK cells can 
promote the priming of CD4+ T helper 
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can also kill activated T cells, unless the T 
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or non-classical MHC class I molecules. 
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dependent autoimmunity (Lu et al., 2007). 
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of protective immunity is still a matter of 
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efficiency of vaccines under development.
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stem cell transplantation in acute myeloid 
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monoclonal antibody recognizes KIR2D 
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ecules HLA-C, leading to NK cell-mediated 
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